Gary S. Guthart Sells 7,724 Shares of Intuitive Surgical, Inc. (ISRG) Stock
Intuitive Surgical, Inc. (NASDAQ:ISRG) CEO Gary S. Guthart sold 7,724 shares of the stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $414.50, for a total transaction of $3,201,598.00. Following the sale, the chief executive officer now directly owns 275,220 shares of the company’s stock, valued at $114,078,690. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Intuitive Surgical, Inc. (NASDAQ ISRG) opened at $392.91 on Monday. Intuitive Surgical, Inc. has a fifty-two week low of $233.66 and a fifty-two week high of $452.00. The firm has a market cap of $44,020.00, a P/E ratio of 69.17, a P/E/G ratio of 4.63 and a beta of 0.50.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.27 by $0.27. Intuitive Surgical had a net margin of 21.09% and a return on equity of 19.93%. The company had revenue of $892.40 million for the quarter, compared to the consensus estimate of $866.54 million. During the same quarter in the prior year, the company earned $2.03 EPS. Intuitive Surgical’s quarterly revenue was up 17.9% on a year-over-year basis. research analysts expect that Intuitive Surgical, Inc. will post 7.93 earnings per share for the current year.
ISRG has been the subject of several analyst reports. Barclays reissued an “overweight” rating on shares of Intuitive Surgical in a research report on Friday, October 20th. BidaskClub lowered shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 12th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 price target for the company in a research report on Tuesday, December 12th. Royal Bank of Canada increased their price target on shares of Intuitive Surgical to $430.00 and gave the company a “sector perform” rating in a research report on Friday, January 26th. Finally, Canaccord Genuity reissued a “hold” rating and set a $410.00 price target (up from $380.00) on shares of Intuitive Surgical in a research report on Friday, January 26th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $408.48.
WARNING: “Gary S. Guthart Sells 7,724 Shares of Intuitive Surgical, Inc. (ISRG) Stock” was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://theolympiareport.com/2018/02/12/gary-s-guthart-sells-7724-shares-of-intuitive-surgical-inc-isrg-stock.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.